Go to contents
Go to menu
°Ë»ö¾î ÀÔ·Â
Ȩ
·Î±×ÀÎ
Áñ°Üã±âÃß°¡
ENGLlSH
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Îº°°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
ÇÐȸ/Çùȸ Á¤º¸
Àú³Î Á¤º¸
Àú³Î Åõ°í ±ÔÁ¤
KMbase ¼Ò°³
°øÁö»çÇ×
¾÷µ¥ÀÌÆ® Á¤º¸
³» Á¤º¸
ÀúÀå ³í¹®
°ü½ÉºÐ¾ß ³í¹®
°ü½ÉÇÐȸ/ÇмúÁ¤º¸
¿ø¹®½Åû
°ü½ÉºÐ¾ß °ü¸®
½ºÅ©¸³Æ® ȯ°æ¿¡¼ Áö¿øµË´Ï´Ù.
³í¹®°Ë»ö
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Î°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
SITE LINK
PubMed
Google Scholar
KoreaScience
NDSL
KoreaMed
RISS
MEDLIS
Cross Check
´ëÇѾÏÇÐȸÁö
( Journal of Korean Cancer Research Association )
: °Ë»ö°á°ú :
14
  
°Ë»ö°á°ú¸ðµÎ¼±ÅÃ
1
Çѱ¹¿¡ ÀÖ¾î¼ Áֿ亴¿øÀ» ±Ù°Å·Î ÇÑ ¾Ï¹ß»ýÅë°è
Statistical Observation on the Incidence of Cancer among Korean
( Kim Chong-Sin )
Áøº´È£ ( Chin Byong-Ho )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 143 ~ 149
2
¸Á³»°è¿Í ¾ï¾Ï¼ºÁ¶Á÷ÀÎÀÚÀÇ »óÈ£°ü°è¿¡ °üÇÑ ¿¬±¸
A Study on the Interrelation Between Reticuloendothelial System and Cancer Inhibitory Tissue Factor
Áøº´È£ ( Chin Byong-Ho )
( Cho Myung-Ha )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 127 ~ 142
3
ºñ´¢±â°èÅë ¾Ç¼ºÁ¾¾çÀÇ º´¸®Á¶Á÷ÇÐÀû °Ë»ö
Histopathologic Study on Malignant Tumors of the Urinary Tract
ÃÖ½ÅÀº ( Choi Shin-Eun )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 121 ~ 126
4
µ¿¹°°ñ¼öÀÇ Á¶Á÷¼ºÀåÃËÁø¹°Áú¿¡ °üÇÑ ¿¬±¸
Tissue Growth Promoting Substance in Animal Bone Marrow
Áøº´È£ ( Chin Byong-Ho )
ÀÌ»ó¿Ï ( Lee Sang-Wan )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 107 ~ 119
5
5-iodouracil^131IÀ» ì¦éÄÇÑ äÂàõðþåËÀÇ òàÓ¨¿¡ μÇÑ æÚϼ
An Experimental Study with 5-Iodouracil-^131I on the Diagnosis of Malignant Tumor
( Chin Byoung-Ho )
( Lee Tong-Woo )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 91 ~ 106
6
A Study on Carcinoma of the Breast by Cobalt-60 Teletherapy
Kim, Chung Han/ÑÑïöùÓ
Park, Sang Sook/Moon, Suc Hyong/Kim, Yong Kyu/ÚÓßÂâ×/Ùþà¸úû/ÑÑé»Ð¤
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 83 ~ 89
7
À¯¼Ò¾Æ ¹× ³â¼ÒÀÚ Á¾¾çÀÇ º´¸®Á¶Á÷ÇÐÀû °Ë»ö
A Histopathologic Study on Tumors of Childhood and Adolescence
Lee, Chae Koo/ì°ðÎú
Ham, Eui Keun/Kim, Kyo Young/Chi, Je G./ùàëöÐÆ/ÑÑÎççÈ/ò®ð§ÐÆ
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 75 ~ 81
8
Àڱðæ¾Ï¹ß»ý°úÁ¤¿¡ ÀÖ¾î¼ÀÇ GallocyaninchromalaunÄ¡ÀÇ º¯µ¿¿¡ °üÇÑ Çö¹ÌºÐ±¤Ãø±¤¹ýÀû¿¬±¸
Die Kernfa¡§rbbarkeit mit Gallocyaninchromalaun wa¡§hrend der Krebsentwicklung der Portio uteri an H
...
( Rha Keun-Yeung )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 65 ~ 73
9
ÀÎŹݿ¡¼ ÃßÃâÇÑ ¾ï¾Ï¼ºÁ¶Á÷ÀÎÀÚÀÇ ÀÓ»ó½ÃÇè
Clinical Trial of Cancer Inhibitory Tissue Factor(s) from Human Placenta
Áøº´È£ ( Chin Byong-Ho )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 2È£ 59 ~ 63
10
Clinical Observation on Malignant Lymphoma and Hodgkins Disease
( Lee Kap-Soon )
Áøº´È£ ( Chin Byong-Ho )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 1È£ 51 ~ 57
11
¾Ç¼ºÀÓÆÄÁ¾¿¡ ¾Ëų ÈÁ¦¸¦ »ç¿ëÇÑ Ä¡Çè
Clinical Evaluation of Alkylating Agents in Malignant Lymphoma
±èÁ¾È¯ ( Kim Chong-Whan )
Áøº´È£ ( Chin Byong-Ho )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 1È£ 43 ~ 50
12
À§¾ÏÀÇ À§ÀýÁ¦ÈÄ »ýÁ¸À²
The Survival Rate in Carcinoma of the Stomach
ÀÌâÁÖ ( Lee Chang-Ju )
Áøº´È£ ( Chin Byong-Ho )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 1È£ 37 ~ 42
13
Á¾°Ýµ¿Á¾¾ç¿¡ ´ëÇÑ ÀÓ»ó±Þ º´¸®ÇÐÀû°íÂû
Mediastinal Tumor
( Chang Byong-Ho )
Áøº´È£ ( Chin Byong-Ho )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 1È£ 19 ~ 35
14
°ñ¸· Á¶Á÷¼ºÀå¾ïÁ¦¼º ¹× ÃËÁø¼º¹°Áú¿¡ °üÇÑ ¿¬±¸
Tissue Growth Inhibiting and Promoting Substances in Periosteum
( Chin Byung-Ho )
ÀÌ´ö¿ë ( Lee Duk-Yong )
´ëÇѾÏÇÐȸÁö
1966³â 1±Ç 1È£ 3 ~ 17